GERN

Geron Corporation

1.92 USD
-0.01 (-0.52%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Geron Corporation stock is down -9.86% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 32.14% of the previous 27 February’s closed higher than January. In the last 8 Unusual Options Trades, there were 2 CALLs, 6 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
08 Jan 19:05 21 Jun, 2024 3.00 CALL 1940 1260
12 Jan 19:26 21 Jun, 2024 1.50 PUT 2000 12
24 Jan 19:08 15 Mar, 2024 2.00 CALL 4500 1716
01 Feb 16:53 15 Mar, 2024 2.00 PUT 958 1254
12 Feb 18:24 15 Mar, 2024 2.00 PUT 993 3364
14 Feb 17:13 15 Mar, 2024 2.00 PUT 3890 6558
14 Feb 18:04 15 Mar, 2024 1.50 PUT 2477 8274
16 Feb 18:40 16 Jan, 2026 5.00 PUT 100 5

About Geron Corporation

Geron Corporation focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials. The company was incorporated in 1990 and is headquartered in Foster City, California.